Published in
Elsevier, Drug Discovery Today, 1(27), p. 257-268, 2022
DOI: 10.1016/j.drudis.2021.08.010
Links
Tools
Can preclinical drug development help to predict adverse events in clinical trials?
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 